AccuRx

AccuRx

Private
London, EnglandHealthcare & Life Scienceswww.accurx.com

Last Round

Series B

Sep 15, 2021

Total Funding Raised

$49.61M

Company Overview

Accurx is a healthcare technology company that provides a communication platform for medical professionals to engage with patients through appointment booking, patient questionnaires, online consultations, video consultations, and more.

Sector

Healthcare & Life Sciences

Verticals

Patient Engagement, Vertical SaaS, Telemedicine, EHR & EMR, Enterprise Communication

Business Model

B2G

Customer Profile

Government Contracts, Subscription SaaS, Freemium, Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

healthcare communication platformpatient engagement platformNHS communication toolvideo consultationstelehealth platformpatient triagedigital front doorappointment bookingsecure messagingEHR integrationGP softwareEMIS integrationSystmOne integrationprimary care technologyclinical communicationAI scribing toolclinical scribe AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AccuRx Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

AccuRx Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series BSep 15, 2021
Series AFeb 24, 2019
SeedSep 6, 2016

AccuRx Investors

Notable investors and investment history

InvestorRounds
Trusted InsightSeries B
Encore CapitalSeries B
British Patient CapitalSeries B
LakestarSeries B
LocalGlobeSeries A
AtomicoSeries B, Series A
Entrepreneurs FirstSeries A, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 20, 2026

    Patient Triage product rolled out to manage patient demand.

  • Apr 20, 2026

    Software now supports over 65 million patients annually.

AccuRx Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

AccuRx Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about AccuRx's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon, England
Employee Range260
Year Founded2016
Last FundingSep 15, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.